ASTRAZENECA PLC

(AZN)
  Rapport
Temps réel estimé Cboe Europe  -  25/05 13:10:30
10570.00 GBX   -0.26%
12:04ASTRAZENECA : Opinion positive de JP Morgan
ZD
24/05ASTRAZENECA PLC : Danske Bank Group revoit son opinion à la hausse
ZM
24/05L'organisme de réglementation des médicaments de l'UE approuve le vaccin COVID-19 d'AstraZeneca comme troisième dose de rappel
MT
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur ASTRAZENECA PLC
12:03French health body backs new COVID vaccine booster campaign for this autumn
08:03L'agenda della settimana
24/05NEOSPERIENCE : con AstraZenenca lancia piattaforma "Haya"
24/05Indian vaccine giant Serum plans African plant in global expansion
24/05Vaxzevria approved in the EU as third dose booster against COVID-19
24/05AstraZeneca aims to transform cancer care with practice-changing data at ASCO 2022
24/05AstraZeneca COVID-19 vaccine approved in the EU as third dose booster against COVID-19
24/05Trial Scheduled For April 2024 In BMS Patent Case Against AstraZeneca Regarding Anti-PD..
24/05EU Drug Regulator Approves AstraZeneca's COVID-19 Vaccine as Third-Dose Booster
23/05U.S. Task Force to consider routine kidney disease screening as new drugs available
23/05Serum, el gigante indio de las vacunas, planea una planta en África
23/05What you need to know about the coronavirus right now
23/05AstraZeneca's COVID-19 Vaccine Gets EU Approval as Third Booster Dose
23/05AstraZeneca aims to transform cancer care with practice-changing data at ASCO 2022
23/05CORONA-BLOG/ASTRAZENECA : Vaxzevria nun in der EU als Booster zugelassen
23/05AstraZeneca says COVID shot approved in EU as booster
23/05L'agenda della settimana
23/05AstraZeneca's Covid-19 Vaccine Gets EU Approval for Third Doses
20/05L'agenda della prossima settimana
20/05Astrazeneca's Healthy Heart Africa Screens 3.9 Million Ugandans for Hypertension
19/05EU health regulator backs using AstraZeneca COVID shot as booster
18/05AstraZeneca signs licence agreement with RQ Biotechnology for monoclonal antibodies aga..
18/05From storage to transport, hurdles to getting COVID vaccine to N.Koreans
17/05What you need to know about the coronavirus right now
17/05AstraZeneca Obtains Exclusive Global License To Develop Antibodies Against COVID-19
17/05FTSE 100 lags European peers on strong pound
17/05AstraZeneca refuerza sus terapias contra el COVID con la compra de RQ Bio
17/05RQ Biotechnology Ltd Signs Licensing Agreement with AstraZeneca PLC
16/05AstraZeneca Expands License Deal With Drug Discovery Startup to Develop Cancer Therapie..
16/05AstraZeneca Expands Oncology Collaboration With Proteros
16/05Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca
16/05FTSE 100 rises as healthcare, resource-linked gains offset China jitters
16/05NetScientific Shares Rise on Successful Completion of AstraZeneca Covid-19 Antibody Tes..
16/05PT027, a novel fixed-dose combination of albuterol and budesonide, used as an as-needed..
16/05AstraZeneca's Asthma Drug Cuts Risk Of Severe Exacerbations In Late-stage Study
15/05PT027, a Novel Fixed-Dose Combination of Albuterol and Budesonide, Used as an As-Needed..
13/05AstraZeneca, Baili Launch Clinical Trial Collaboration for Lung Cancer Drug Combination
13/05Baili Announces Clinical Trial Collaboration to Evaluate SI-B001, an EGFR x HER3 bispec..
13/05COREA DEL SUD : vuole inviare vaccini anti-Covid a Pyongyang
13/05Human ventricular progenitor cells promote the formation of new heart tissue following ..
13/05N.Korea gets offers of aid to fight COVID as it lacks vaccines
12/05AstraZeneca Joins Accumulus Synergy as a Sponsor to Accelerate the Delivery of Medicine..
11/05Sanofi Says Nirsevimab Showed Nearly 80% Efficacy Against Respiratory Syncytial Virus
11/05Sanofi-AstraZeneca's Respiratory Syncytial Virus Drug Shows 80% Efficacy in Pooled Data..
10/05Emergent Discarded 400 Million Vaccine Doses Over Quality Issues, Congressional Report ..
10/05Financials and healthcare shares lift FTSE 100
09/05Los fabricantes de vacunas de COVID pasan a centranse en los refuerzos
09/05COVID vaccine makers shift focus to boosters
09/05Alligator Bioscience expands its Board of Directors with the appointment of Staffan Enc..
06/05Obesity may weaken vaccine protection; unvaccinated Omicron patients face risk from var..
05/05AstraZeneca, Daiichi Sankyo Say US FDA Clears Enhertu to Treat Breast Cancer; AstraZene..
05/05AstraZeneca Says Phase 3 Trial of Farxiga for Heart Failure Meets Primary Endpoint
05/05ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US for patients with HER2-po..
05/05FARXIGA met primary endpoint in DELIVER Phase III trial, reducing risk of cardiovascula..
05/05Farxiga Met Primary Endpoint in Deliver Phase III Trial, Reducing Risk of Cardiovascula..
05/05ULTOMIRIS® (ravulizumab-cwvz) Met Primary Endpoint in CHAMPION-NMOSD Phase III Trial in..
05/05Ultomiris met primary endpoint in CHAMPION-NMOSD Phase III trial in adults with neuromy..
05/05Farxiga met primary endpoint in DELIVER Phase III trial, reducing risk of cardiovascula..
05/05Enhertu approved in the US for patients with HER2-positive metastatic breast cancer tr..
05/05SIMON THOMPSON : FTSE 100 Seen Higher on Fed Rate Prospects; BOE Awaited
05/05AstraZeneca, Daiichi's Breast Cancer Treatment Wins US Approval
05/05AstraZeneca's Farxiga Cuts Risk of Cardiovascular Death in Late-Stage Study
05/05AstraZeneca's Rare Inflammatory Disease Drug Cuts Risk Of Relapse Among Adults In Late-..
05/05AstraZeneca and Daiichi Sankyo's Enhertu (Trastuzumab Deruxtecan) Announces Approval in..
05/05Astrazeneca plc Announces High-Level Results from the Deliver Phase III Trial
05/05AstraZeneca's Enhertu Approved in US for Metastatic Breast Cancer Treatment
05/05AstraZeneca Says Farxiga Heart Treatment Phase 3 Trial Met Primary Endpoint
05/05AstraZeneca Says Autoimmune Disease Treatment Ultomiris Met Phase 3 Trial Primary Endpo..
04/05WHO-Chef kritisiert Pharmafirmen - 'moralisches Versagen'
04/05AstraZeneca's Imfinzi Plus Chemotherapy Receives FDA Priority Review for Biliary Tract ..
04/05Imfinzi Plus Chemotherapy Granted Priority Review in the US for Patients With Locally A..
04/05Imfinzi Plus Chemotherapy Granted Priority Review in the US for Patients With Locally A..
04/05Imfinzi plus chemotherapy granted Priority Review in the US for patients with locally a..
04/05AstraZeneca Gets US FDA's Priority Review For Biliary Tract Cancer Combo Treatment
04/05Astrazeneca plc Announces Chemotherapy Granted Priority Review in the US for Patients w..
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur ASTRAZENECA PLC